Celltechna
Manufacturing · Lithuania · 11-50 Employees
View Company Info for Free
Overview
Headquarters
21-43 S Žukausko St, Vilnius, Vilnius Co...Phone Number
+370 52107013Website
www.celltechna.comRevenue
$8.4 MillionIndustry
About Celltechna
Is Celltechna your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Celltechna recently announced quarterly report
Click to see if Celltechna had a recent Job posting/layoffs
Check if Celltechna has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Celltechna has new funding data
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Celltechna launches new products
Congratulate Masked Content for being promoted to Masked Content at Celltechna
Check out if Celltechna is spiking on competitors!
Celltechna, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Celltechna as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Celltechna is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Celltechna is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Celltechna.
Celltechna Tech Stack
A closer look at the technologies used by Celltechna
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Celltechna
Celltechna is a biopharmaceutical company focused on developing innovative and biosimilar biologic medical product technologies for clinical development and large-scale production. The company aims to collaborate with large and mid-size pharmaceutical companies that lack the internal capabilities to develop or produce materials for clinical develop... Read More